Back to Avoro Capital Advisors LLC

XENE
Showing 8 of 29 quarters

Position history for Avoro Capital Advisors LLC's holdings in XENON PHARMACEUTICALS INC

Avoro Capital Advisors LLC holds 5.8M shares of XENE (XENON PHARMACEUTICALS INC), worth $336M as of 2026-Q1. The position was increased (+6.5% shares). XENE represents 3.3% of Avoro Capital Advisors LLC's portfolio.

Current Value

$336M

Current Shares

5.8M

Total Value Change

+$115M

Total Shares Change

+111,111

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
5.8M
+6.5%
$336M3.3%$43.79
62
2025-Q4
Increased
5.4M
+0.5%
$243.1M2.4%$44.12
54
2025-Q3
Unchanged
5.4M
0.0%
$216.8M2.8%$39.06
0
2025-Q2
Decreased
5.4M
-6.0%
$169M3.0%$32.40
0
2025-Q1
Increased
5.7M
+1.3%
$192.6M3.0%$34.26
58
2024-Q4
Unchanged
5.7M
0.0%
$222.1M3.1%$38.53
0
2024-Q3
Unchanged
5.7M
0.0%
$223.1M3.3%$38.65
0
2024-Q2
Unchanged
5.7M
0.0%
$220.9M2.9%$38.99
0

Other major holders of XENE: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used